Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Supercentenarian Research Foundation (SRF) is a non-profit scientific organization dedicated to the biogerontological study of individuals who have reached the age of 110 or older. Founded in 2004, the foundation aims to uncover the biological mechanisms that allow supercentenarians to escape or significantly delay age-related diseases such as cancer, cardiovascular disease, and neurodegeneration. SRF works in close partnership with the Gerontology Research Group (GRG) to validate the ages of these rare individuals and collect biological samples, including DNA and tissue, for advanced genomic and proteomic analysis. The foundation's research, which includes systematic autopsy studies, seeks to identify longevity-associated genetic variants and biomarkers that could lead to the development of therapies to extend the healthy human lifespan. By studying the most successfully aged humans, SRF provides a unique resource for understanding the limits of human biology and the potential for medical interventions in the aging process.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Supercentenarian Research Foundation.